Jongphil Kim Selected Research

Breast Neoplasms (Breast Cancer)

1/2017	An Exploratory Study to Determine Whether BRCA1 and BRCA2 Mutation Carriers Have Higher Risk of Cardiac Toxicity.
4/2016	Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
10/2013	Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy.
2/2011	A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.
4/2009	Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jongphil Kim Research Topics

Disease

24	Neoplasms (Cancer) 12/2020 - 04/2009
14	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 07/2009
6	Bronchiolitis Obliterans Syndrome 11/2022 - 10/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 05/2012
5	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2009
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 10/2010
4	Adenocarcinoma of Lung 12/2018 - 01/2016
4	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 06/2015
3	Adenocarcinoma 01/2022 - 04/2016
3	Multiple Myeloma 12/2020 - 06/2012
3	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 08/2011
3	Mucositis 08/2014 - 07/2010
2	Infections 11/2021 - 01/2021
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 05/2020 - 03/2013
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 07/2012
2	Leukemia 06/2015 - 07/2009
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Anemia 01/2021
1	Cytopenia 01/2021
1	Cytokine Release Syndrome 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 12/2020
1	Carcinogenesis 01/2020
1	Nausea 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	Pain (Aches) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Injection Site Reaction 12/2018
1	Fatigue 12/2018
1	Hyperplasia 01/2018
1	Lung Neoplasms (Lung Cancer) 12/2017
1	Glioblastoma (Glioblastoma Multiforme) 12/2017

Drug/Important Bio-Agent (IBA)

6	GlucocorticoidsIBA 11/2022 - 07/2009
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2013
5	Busulfan (Busulfex)FDA Link 06/2015 - 10/2010
4	Gemcitabine FDA Link 01/2021 - 08/2011
4	Messenger RNA (mRNA)IBA 12/2017 - 04/2016
4	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 07/2010
4	Tacrolimus (Prograf)FDA LinkGeneric 07/2015 - 07/2010
3	Sirolimus (Rapamycin)FDA Link 07/2015 - 07/2009
3	fludarabineIBA 06/2015 - 02/2011
3	Docetaxel (Taxotere)FDA Link 11/2014 - 08/2011
2	ofatumumab FDA Link 11/2022 - 06/2015
2	Capecitabine (Xeloda)FDA Link 01/2022 - 08/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 11/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 07/2009
2	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 06/2012
2	AndrogensIBA 01/2019 - 01/2018
2	enzalutamideIBA 01/2019 - 12/2017
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 04/2016
2	Histones (Histone)IBA 12/2017 - 04/2009
2	Fluorescent Dyes (Fluorescent Probes)IBA 04/2016 - 02/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2016 - 01/2016
2	Bortezomib (Velcade)FDA Link 11/2015 - 06/2012
1	Prednisone (Sone)FDA LinkGeneric 11/2022
1	lenvatinibIBA 01/2022
1	axicabtagene ciloleucelIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	copanlisibIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	EltanexorIBA 12/2020
1	selinexorIBA 12/2020
1	Exportin 1 ProteinIBA 12/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	regorafenibIBA 01/2020
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2020
1	Beclomethasone (Beclometasone)FDA Link 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2019
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	CannabinoidsIBA 01/2019
1	VaccinesIBA 12/2018
1	Chemokine CCL21IBA 12/2018
1	CD40 Ligand (CD40L)IBA 12/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Kisspeptin-1 ReceptorsIBA 12/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2017

Therapy/Procedure

13	Therapeutics 11/2022 - 07/2009
13	Cell Transplantation 11/2021 - 07/2009
8	Drug Therapy (Chemotherapy) 01/2021 - 07/2010
5	Radiotherapy 01/2022 - 04/2014
5	Transplantation 11/2021 - 02/2011
2	Neoadjuvant Therapy 01/2022 - 10/2013
2	Homologous Transplantation 11/2021 - 10/2010
2	Hematopoietic Stem Cell Transplantation 01/2021 - 11/2011
2	Mastectomy (Mammectomy) 05/2020 - 03/2013
2	Salpingo-oophorectomy 05/2020 - 07/2017
2	Induction Chemotherapy 01/2020 - 08/2011
2	Castration 01/2018 - 12/2017
1	Adjuvant Chemotherapy 01/2022
1	Autologous Transplantation 12/2020
1	Lymph Node Excision (Lymph Node Dissection) 06/2018